Orthofix announces FITBONE innovation at POSNA 2026 meeting

Orthofix (OFIX) Medical announced new pediatric limb reconstruction innovations that expand treatment options for pediatric and small stature patients. The Company will highlight these advances at the Pediatric Orthopedic Society of North America 2026 Annual Meeting, which takes place May 6-8, 2026, at the Rosen Shingle Creek Hotel in Orlando, Florida. At POSNA 2026, Orthofix will showcase its comprehensive pediatric limb reconstruction portfolio at exhibit booth #34, including the recently launched FITBONE Trochanteric Intramedullary Lengthening System and new enhancements to its OrthoNext planning software platform. At the meeting, Orthofix will highlight the following innovations: FITBONE Trochanteric Lengthening System – The FITBONE Trochanteric Lengthening System expands Orthofix’s internal limb-lengthening nail portfolio with a new femoral-lengthening option featuring a trochanteric entry design. The bone-conserving, minimally invasive approach supports both adult and pediatric patients aged 12-21 who may require an alternative entry point through the greater trochanter. With the smallest proximal diameter of any intramedullary lengthening device currently available, the system enables greater procedural flexibility for patients who were previously more challenging to treat. OrthoNext 2.1 Planning Software for TL-HEX – OrthoNext 2.1 enhances the capabilities of the TrueLok Hexapod System by extending comprehensive deformity analysis, correction planning, and templating across internal and external fixation procedures. New features include strut event calendar scheduling; independent second-ring movement for preoperative planning; automatic marker identification for postoperative X-ray calibration; and 3D ring modeling with ring position recovery to help surgeons plan and execute complex corrections more efficiently.